COVID-19 Feature Stories

Stories that highlight UNC Health and UNC School of Medicine's response to COVID-19.

SOM Students Rally to Help Health Care Workers through the Fight Against COVID-19

SOM Students Rally to Help Health Care Workers through the Fight Against COVID-19

UNC School of Medicine students across campuses are organizing multiple volunteer projects all with one aim – help hospitals safely and effectively combat COVID-19. From making PPE to organizing child care, these students are doing whatever they can to make a difference.

SOM Students Rally to Help Health Care Workers through the Fight Against COVID-19 - Read More…

Meet UNC School of Medicine’s COVID-19 Research Heroes

Meet UNC School of Medicine’s COVID-19 Research Heroes

The UNC School of Medicine has researchers across disciplines working together to combat the COVID-19 pandemic.

Meet UNC School of Medicine’s COVID-19 Research Heroes - Read More…

New Antiviral Drug Heading into Clinical Trials Offers Hope as COVID-19 Treatment, Could be Taken as a Pill

New Antiviral Drug Heading into Clinical Trials Offers Hope as COVID-19 Treatment, Could be Taken as a Pill

A study co-led by the lab of Ralph Baric, PhD, found that a compound called EIDD-2801 can prevent severe lung injury in mice infected with SARS-CoV-2, the virus that causes COVID-19.

New Antiviral Drug Heading into Clinical Trials Offers Hope as COVID-19 Treatment, Could be Taken as a Pill - Read More…

UNC Begins Plasma Collection for Treating COVID-19 Patients

UNC Begins Plasma Collection for Treating COVID-19 Patients

The UNC Medical Center is now collecting convalescent plasma from recovered COVID-19 patients to help current UNC Health COVID-19 patients, under FDA guidelines. UNC School of Medicine researchers are planning a clinical trial to analyze coronavirus antibody responses in patients who receive convalescent plasma.

UNC Begins Plasma Collection for Treating COVID-19 Patients - Read More…

UNC Researchers Featured in Podcast on Future Pandemic Readiness

UNC Researchers Featured in Podcast on Future Pandemic Readiness

This Week in Virology featured three UNC-Chapel Hill researchers talking about READDI, a $125-million initiative designed to start making drugs now for the next pandemic.

UNC Researchers Featured in Podcast on Future Pandemic Readiness - Read More…

Researchers Publish Clinical Data on Remdesivir Treatment for COVID-19

Researchers Publish Clinical Data on Remdesivir Treatment for COVID-19

The nation’s coronavirus task force announced clinical trial results for remdesivir, a treatment from Gilead Sciences that emerged as a possible coronavirus treatment in the lab of Ralph Baric, PhD.

Researchers Publish Clinical Data on Remdesivir Treatment for COVID-19 - Read More…

Scientists Reveal Host- SARS-CoV-2 Protein Targets for Drug Repurposing

Scientists Reveal Host- SARS-CoV-2 Protein Targets for Drug Repurposing

The lab of Bryan Roth, MD, PhD, was part of a large research project led by the University of California-San Francisco to identify viral proteins and virus-host protein interactions that could become important drug targets to treat people with COVID-19.

Scientists Reveal Host- SARS-CoV-2 Protein Targets for Drug Repurposing - Read More…

SOM Students Value Team Approach to Vital COVID-19 Response Effort

SOM Students Value Team Approach to Vital COVID-19 Response Effort

Medical students Alex Gertner, Demitra Canoutas, Ryan Searcy, Alex Gregor, and Sean Donohue are among the student, staff, and faculty volunteers to help make personal protective equipment for front line healthcare workers.

SOM Students Value Team Approach to Vital COVID-19 Response Effort - Read More…

Schisler Collaborates with NASA to Study COVID-19, Protein Correlation

Schisler Collaborates with NASA to Study COVID-19, Protein Correlation

An interdisciplinary research working group on space biology formed by NASA has transformed into the Coronavirus International Research Team, which includes Jonathan Schisler, PhD, at the UNC School of Medicine.

Schisler Collaborates with NASA to Study COVID-19, Protein Correlation - Read More…

UNC, EPA Researchers, Infection Prevention Experts Create Hierarchy of Mask Alternatives

UNC, EPA Researchers, Infection Prevention Experts Create Hierarchy of Mask Alternatives

With facemask donations pouring in and a proliferation of instructional videos for fabricating masks at home, UNC and EPA researchers are collaborating with infection prevention experts to test the performance of masks on campus, with the goal of providing UNC Health workers with the safest available masks at all times. The research collaboration is led by Emily Sickbert-Bennett, PhD, and Phillip Clapp, PhD.

UNC, EPA Researchers, Infection Prevention Experts Create Hierarchy of Mask Alternatives - Read More…

UNC Doctors, Students Collaborate on COVID Treatment Study

UNC Doctors, Students Collaborate on COVID Treatment Study

In the first COVID-19 case series of tocilizumab in the United States, UNC-Chapel Hill researchers and students from the UNC School of Medicine and Gillings School of Global Public Health, report that the drug tocilizumab should be used judiciously until randomized clinical trials determine the drug’s true efficacy for severely ill patients.

UNC Doctors, Students Collaborate on COVID Treatment Study - Read More…